Physician profile
Robert I Russell
NPI 1265420673
$6,853.06
in general payments reported to CMS, 2019-2025
26 companies · $716 in 2025
The $716 reported for 2025 was more than what 80% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,945 · 2020: $641 · 2021: $600 · 2022: $891 · 2023: $1,375 · 2024: $685 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,812.87 | 2019-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Affinity |
| Paratek Pharmaceuticals, INC. | $1,006.20 | 2021-2025 | Nuzyra |
| Stryker Corporation | $870.92 | 2022-2023 | Ortholoc 2 Lapifuse, Salvation, Fuseforce |
| Musculoskeletal Transplant Foundation INC. | $842.18 | 2019-2021 | |
| Convatec INC. | $254.22 | 2023-2025 | |
| Smith+Nephew, INC. | $210.48 | 2019-2022 | |
| Horizon Therapeutics Plc | $156.73 | 2021-2023 | Krystexxa |
| Amgen INC. | $121.84 | 2025 | Krystexxa |
| Aroa Biosurgery Incorporated | $107.41 | 2019-2023 | |
| Solventum Corporation | $98.60 | 2024 | V.A.C. Veraflo |
| Bioventus LLC | $43.53 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $40.63 | 2021-2022 | |
| Grt US Holding, INC. | $40.44 | 2020-2021 | |
| Globus Medical, INC. | $31.53 | 2025 | Senza |
| Mckesson Patient Care Solutions INC. | $27.69 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $24.22 | 2019 | |
| Allergan, INC. | $22.36 | 2020 | |
| Medtronic, INC. | $20.25 | 2022 | |
| Alfasigma USA, INC. | $18.97 | 2022 | |
| Depuy Synthes Sales INC. | $15.62 | 2022 | |
| Heron Therapeutics, INC. | $15.60 | 2021 | |
| Paragon 28, INC. | $15.12 | 2019 | |
| Boston Scientific Corporation | $15.01 | 2024 | |
| Merck Sharp & Dohme LLC | $14.04 | 2019 | |
| Orthofix Medical, INC. | $13.80 | 2023 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.